ArticleBlood2015

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.

Soranobu Ninomiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.